| 摘要 |
FIELD: medicine; pharmacology. ^ SUBSTANCE: invention refers to pharmaceutical combination of antihypertensive action rennin inhibitor in effective amount of formula or its pharmaceutically acceptable salt and, at least, one therapeutic agent chosen from group, including (II) HmG-CoA-reductase inhibitor or its pharmaceutically acceptable salt, (IV) calcium channel-blocking agent or its pharmaceutically acceptable salt, (V) aldosteronsynthase inhibitor or its pharmaceutically acceptable salt and (IX) diuretic or its pharmaceutically acceptable salt, and the carrier. Besides, discovered is method of prevention, delayed development, treatment of disease or condition and application of combination for preparation of medical product. ^ EFFECT: combinations under the invention manifest synergetic therapeutic action. ^ 10 cl, 16 ex |
